Angiotensin-receptor blockers: Benefits beyond lowering blood pressure

被引：4
|
作者：
Silverstein, RL
Ram, CVS
机构：
[1] Texas Blool Pressure Inst, Dallas Nephrol Associates, Dallas, TX 75235 USA
[2] Univ Texas, SW Med Sch, Dallas, TX USA
来源：
CLEVELAND CLINIC JOURNAL OF MEDICINE | 2005年 / 72卷 / 09期
关键词：
D O I：
10.3949/ccjm.72.9.825
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A number of controlled clinical trials provide evidence that angiotensin-receptor blockers improve the prognosis in a variety of conditions that place patients at high cardiovascular risk. The effect is more than one would expect from the effect of these agents on blood pressure alone. The results of some of these trials have expanded the indications for these drugs.
引用
收藏
页码：825 / 832
页数：8
相关论文
共 50 条
12345